Your browser doesn't support javascript.
loading
The Role of Myeloid-Derived Suppressor Cells in the Treatment of Pancreatic Cancer.
Dong, Peng; Yan, Yu; Fan, Yujun; Wang, Hui; Wu, Danzhu; Yang, Liyuan; Zhang, Junpeng; Yin, Xiaoyang; Lv, Yajuan; Zhang, Jiandong; Hou, Yuzhu; Liu, Fengjun; Yu, Xinshuang.
Afiliación
  • Dong P; Department of oncology, 66310The First affiliated hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Shandong, China.
  • Yan Y; Department of oncology, 66310The First affiliated hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Shandong, China.
  • Fan Y; Medical Management Center，66310Health Commission of Shandong Province, Jinan, Shandong, China.
  • Wang H; Department of oncology, 66310The First affiliated hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Shandong, China.
  • Wu D; Department of oncology, 66310The First affiliated hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Shandong, China.
  • Yang L; Department of Oncology, Clinical Medical College of Jining Medical University, Jining, Shandong, China.
  • Zhang J; Department of oncology, 66310The First affiliated hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Shandong, China.
  • Yin X; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, 66310Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Lv Y; Department of Oncology, The Second Hospital, Cheeloo College of Medicine Shandong University, Jinan, China.
  • Zhang J; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, 66310Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Hou Y; Department of oncology, 66310The First affiliated hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Shandong, China.
  • Liu F; Department of oncology, 66310The First affiliated hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Lung Cancer Institute, Shandong, China.
  • Yu X; Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, ShaanXi, China.
Technol Cancer Res Treat ; 21: 15330338221142472, 2022.
Article en En | MEDLINE | ID: mdl-36573015
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Células Supresoras de Origen Mieloide / Neoplasias Idioma: En Revista: Technol Cancer Res Treat Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Células Supresoras de Origen Mieloide / Neoplasias Idioma: En Revista: Technol Cancer Res Treat Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article